In this study, we sought to assess the role of two SWI/SNF BAF subunits (the tumor suppressor BAF47 and BAF53a) and the catalytic subunit BRG1 in skeletal muscle terminal differentiation. The gene discussed is SMARCA4; the disease is neoplasm.